Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116178393B reveals a novel one-step synthesis for indole δ-sultone compounds. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN113527388A details a novel DPPA-mediated method for beta-2-deoxy sugar synthesis, offering high stereoselectivity and mild conditions for API manufacturing.
Patent CN103275146A details a novel Lewis acid-catalyzed route for gastrodin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability through stable intermediates.
Patent CN109867637A reveals efficient synthesis for fumidil amido alcohol. Offers supply chain stability and cost reduction for veterinary drug manufacturing partners.
Patent CN102850377B reveals a cost-effective Fe/Cu catalytic route for Levofloxacin Hydrochloride, offering high purity and scalable API intermediate manufacturing solutions.
Novel synthesis route for TL214 impurity ensures high purity and supply stability for DPP-4 inhibitor quality control processes globally. This method offers significant cost reduction in pharmaceutical intermediates manufacturing while maintaining stringent quality standards for regulatory compliance.
Novel 3-step route for bilastine intermediate via Pd-catalysis. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN117402085B reveals a novel route for Sacubitril intermediates. Achieve high purity and cost reduction in API manufacturing with scalable processes.
Novel Friedel-Crafts route for Canagliflozin intermediate. High purity, scalable process reducing raw material complexity for global supply chains.
Patent CN102603652A reveals a mild three-step synthesis for 5-formylpyrimidine carbocyclic nucleosides, offering a reliable route for antiviral intermediate manufacturing.
Advanced preparation method for Telmisartan intermediates featuring high yield, mild conditions, and avoidance of toxic cyanide. Ideal for scalable pharmaceutical manufacturing.
Patent CN102219779A details a high-yield Irbesartan synthesis avoiding toxic tin reagents. Discover cost-effective manufacturing and supply chain advantages.
Patent CN113200997B details scalable route for high-purity pharmaceutical intermediates with cost-effective raw materials and simplified purification steps.
Patent CN107746390B reveals a high-yield diclazuril preparation method eliminating iron mud waste, offering cost reduction in veterinary drug manufacturing and reliable supply.
Patent CN107973747A details a high-yield chlorination process enhancing supply chain stability and reducing manufacturing costs for global pharmaceutical intermediate procurement.
Patent CN103193753B reveals acidic ionic liquid catalysis for xanthene dione derivatives, offering high yield and recyclability for pharmaceutical intermediate supply chains.
Patent CN108358913A offers green synthesis for Rotundine Sulfate. Reduces cost and improves yield for pharmaceutical intermediates supply chain.
Novel gold-catalyzed route for aryl indole intermediates ensures high yield and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN107098950B reveals a novel liquid-phase synthesis for GHK tripeptides offering superior purity and cost efficiency for global supply chains.
Novel copper-catalyzed decarboxylative acylation method offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.